Co-Authors
This is a "connection" page, showing publications co-authored by Hans Hirsch and Marcel Stoeckle.
Connection Strength
0.173
-
Ninety-day outcome of patients with severe COVID-19 treated with tocilizumab - a single centre cohort study. Swiss Med Wkly. 2021 08 02; 151:w20550.
Score: 0.060
-
Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect. J Antimicrob Chemother. 2020 10 01; 75(10):3084-3086.
Score: 0.057
-
Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations. Antimicrob Agents Chemother. 2020 08 20; 64(9).
Score: 0.056